1999
DOI: 10.1038/sj.bjp.0702928
|View full text |Cite
|
Sign up to set email alerts
|

Effects of inhibitors of the activity of poly (ADP‐ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock

Abstract: 1 Poly (ADP-ribose) synthetase (PARS) is a nuclear enzyme activated by strand breaks in DNA, which are caused by reactive oxygen species (ROS). Here we investigate the e ects of the PARS inhibitors 3-aminobenzamide (3-AB), nicotinamide and 1,5-dihydroxyisoquinoline (ISO) on the circulatory failure and the organ injury/dysfunction caused by haemorrhage and resuscitation in the anaesthetized rat. 2 Haemorrhage (su cient to lower mean arterial blood pressure to 50 mmHg for 90 min) and subsequent resuscitation wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
19
0

Year Published

2000
2000
2008
2008

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(20 citation statements)
references
References 42 publications
1
19
0
Order By: Relevance
“…The experimental data suggests that this ªPARS suicide mechanismº is involved in many of fundamental disturbances of endotoxic shock, including endothelial dysfunction [4], loss of vascular energetic and contractile failure [5,6], pulmonary endothelial and intestinal mucosal hyperpermeability [7], and impairment of mitochondrial respiration [8,9]. Moreover, strategies aimed at inhibiting PARS activity have exerted beneficial effects in various experimental models, including myocardial [10], renal [11], and splanchnic [12] ischemia-reperfusion injury or hemorrhagic shock [13]. In a rat model of endotoxic shock treatment with the PARS inhibitor, nicotinamide prevented the delayed vascular failure and restored the endotoxin (LPS)-induced loss of vascular contractility [5].…”
Section: Introductionmentioning
confidence: 99%
“…The experimental data suggests that this ªPARS suicide mechanismº is involved in many of fundamental disturbances of endotoxic shock, including endothelial dysfunction [4], loss of vascular energetic and contractile failure [5,6], pulmonary endothelial and intestinal mucosal hyperpermeability [7], and impairment of mitochondrial respiration [8,9]. Moreover, strategies aimed at inhibiting PARS activity have exerted beneficial effects in various experimental models, including myocardial [10], renal [11], and splanchnic [12] ischemia-reperfusion injury or hemorrhagic shock [13]. In a rat model of endotoxic shock treatment with the PARS inhibitor, nicotinamide prevented the delayed vascular failure and restored the endotoxin (LPS)-induced loss of vascular contractility [5].…”
Section: Introductionmentioning
confidence: 99%
“…These observations indicate that all of the conditions required for PARP activation are present in HS. Previous studies testing pharmacological inhibitors of PARP in experimental HS suffered from problems with the limited selectivity of the inhibitor for PARP and their relatively low potency (12,13). In the present study, we have investigated in more detail the potential role PARP activation may play in HS by using genetically engineered animals lacking the PARP gene.…”
mentioning
confidence: 99%
“…Inhibitors of PARP attenuated the hepatic damage after hemorrhagic shock (17,36) but did not reduce liver injury after I/R (4). Although detection of cleaved PARP (89 kDa) is used for the assessment of apoptosis in the liver (38), hepatocellular PARP has been recently shown to be resistant to caspase-induced proteolytic cleavage (9).…”
mentioning
confidence: 99%